WO2005074898A3 - Nouvelle combinaison pour le traitement d'helicobacter pylori - Google Patents

Nouvelle combinaison pour le traitement d'helicobacter pylori Download PDF

Info

Publication number
WO2005074898A3
WO2005074898A3 PCT/EP2005/050337 EP2005050337W WO2005074898A3 WO 2005074898 A3 WO2005074898 A3 WO 2005074898A3 EP 2005050337 W EP2005050337 W EP 2005050337W WO 2005074898 A3 WO2005074898 A3 WO 2005074898A3
Authority
WO
WIPO (PCT)
Prior art keywords
pantoprazole
antibiotic
composition
helicobacter pylori
treating helicobacter
Prior art date
Application number
PCT/EP2005/050337
Other languages
English (en)
Other versions
WO2005074898A2 (fr
Inventor
Reinhard Huber
Bernhard Kohl
Wolfgang Kromer
Wolfgang-Alexander Simon
Original Assignee
Altana Pharma Ag
Reinhard Huber
Bernhard Kohl
Wolfgang Kromer
Wolfgang-Alexander Simon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag, Reinhard Huber, Bernhard Kohl, Wolfgang Kromer, Wolfgang-Alexander Simon filed Critical Altana Pharma Ag
Publication of WO2005074898A2 publication Critical patent/WO2005074898A2/fr
Publication of WO2005074898A3 publication Critical patent/WO2005074898A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

L'invention concerne des compositions pharmaceutiques ainsi que leur utilisation dans le traitement ou la prévention de troubles gastro-intestinaux, plus spécifiquement des troubles provoqués ou exacerbés par une infection d'helicobacter et l'acide gastrique sécrété.
PCT/EP2005/050337 2004-01-28 2005-01-27 Nouvelle combinaison pour le traitement d'helicobacter pylori WO2005074898A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04001756.8 2004-01-28
EP04001756 2004-01-28

Publications (2)

Publication Number Publication Date
WO2005074898A2 WO2005074898A2 (fr) 2005-08-18
WO2005074898A3 true WO2005074898A3 (fr) 2006-07-27

Family

ID=34833547

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/050337 WO2005074898A2 (fr) 2004-01-28 2005-01-27 Nouvelle combinaison pour le traitement d'helicobacter pylori

Country Status (1)

Country Link
WO (1) WO2005074898A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI463998B (zh) * 2009-12-31 2014-12-11 Synmosa Biopharma Corp Amoxicillin and clomycin have a high absorption rate of pharmaceutical ingredients
CN104814964B (zh) * 2015-04-16 2018-07-31 广东赛烽医药科技有限公司 一种抗胃幽门螺旋杆菌的药物组合物、制备方法及其应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003135A1 (fr) * 1990-08-24 1992-03-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Compositions pharmaceutiques contenant du 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyle) methylsulfinyle]benzimidazole et un agent anti-helicobacter pour le traitement des troubles gastro-intestinaux
US5888535A (en) * 1993-04-27 1999-03-30 Sepracor Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
WO2000010995A1 (fr) * 1998-08-18 2000-03-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouvelle forme de sel de pantoprazole
WO2000074654A1 (fr) * 1999-06-07 2000-12-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Preparation et forme galenique comprenant un compose actif acido-labile
US20030136698A1 (en) * 2000-06-27 2003-07-24 Andreas Klatt Medicinal product package for eradication therapy

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003135A1 (fr) * 1990-08-24 1992-03-05 Byk Gulden Lomberg Chemische Fabrik Gmbh Compositions pharmaceutiques contenant du 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyle) methylsulfinyle]benzimidazole et un agent anti-helicobacter pour le traitement des troubles gastro-intestinaux
US5888535A (en) * 1993-04-27 1999-03-30 Sepracor Inc. Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
WO2000010995A1 (fr) * 1998-08-18 2000-03-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Nouvelle forme de sel de pantoprazole
WO2000074654A1 (fr) * 1999-06-07 2000-12-14 Byk Gulden Lomberg Chemische Fabrik Gmbh Preparation et forme galenique comprenant un compose actif acido-labile
US20030136698A1 (en) * 2000-06-27 2003-07-24 Andreas Klatt Medicinal product package for eradication therapy

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KALE-PRADHAN PRAMODINI B ET AL: "Esomeprazole for acid peptic disorders", ANNALS OF PHARMACOTHERAPY, vol. 36, no. 4, April 2002 (2002-04-01), pages 655 - 663, XP009030827, ISSN: 1060-0280 *
TANAKA MAKOTO ET AL: "Stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor, in extensive and poor metabolizers of S-mephenytoin", CLINICAL PHARMACOLOGY AND THERAPEUTICS, vol. 69, no. 3, March 2001 (2001-03-01), pages 108 - 113, XP009030871, ISSN: 0009-9236 *

Also Published As

Publication number Publication date
WO2005074898A2 (fr) 2005-08-18

Similar Documents

Publication Publication Date Title
WO2005117870A3 (fr) Combinaison d'un inhibiteur de la pompe a protons, d'un agent tampon et d'un agent prokinetique
WO2005091853A3 (fr) Procedes et compositions pour traiter des pathologies associees a l'il-13
WO2007084221A3 (fr) Procédés et appareil pour l'identification de matière dans des données de visualisation
WO2007019439A3 (fr) Compositions de copolymere sequence et utilisations de ces dernieres
WO2007022535A3 (fr) Promedicaments d'agents actifs
WO2008006528A3 (fr) Nouvelles compositions pharmaceutiques comprenant du lévétiracétam
WO2007109192A3 (fr) Composés de bicyclohétéroaryle en tant que modulateurs de p2x7 et leurs utilisations
WO2006084164A3 (fr) Systeme d'administration a retention gastrique et a liberation lente
WO2008009379A3 (fr) Associations de principes actifs présentant des propriétés insecticides et acaricides
WO2006099941A8 (fr) 8-n-benzimidazoles a substitution aminocarbonyle, leur procede de production, et leur utilisation en tant que medicaments
WO2007109172A3 (fr) Composés de bicyclohétéroaryle en tant que modulateurs de p2x7 et leurs utilisations
WO2007028022A3 (fr) Nouveaux composes servant de modulateurs de p2x7 et leurs utilisations
WO2007075794A3 (fr) Formulations orales contenant de la tigecycline
WO2007109154A3 (fr) Composés de bicyclohétéroaryle en tant que modulateurs de p2x7 modulators et leurs utilisations
WO2007109160A3 (fr) Composés de bicyclohétéroaryle en tant que modulateurs de p2x7 et leurs utilisations
WO2007022956A3 (fr) Compositions pharmaceutiques
WO2006120563A3 (fr) Agents antibacteriens
HK1120421A1 (en) Compositions and their preparation methods for inhibiting gastric acid secretion
IL178425A0 (en) Carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
WO2006119309A3 (fr) Composes de 19,26,27-trinor-1$g(a), 25-dihydroxyvitamine d3
HK1048271A1 (en) Pharmaceutical composition for inhibiting retinoidskin damage.
WO2011037411A3 (fr) Composition comprenant une s-allyl-l-cystéine à titre de principe actif pour prévenir ou traiter les troubles gastro-intestinaux
WO2006056696A3 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
RS50581B (sr) Oralne antimikrobijalne farmaceutske kompozicije
WO2007134158A3 (fr) Compositions de calcium

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase